Amicus Therapeutics Inc (FOLD)
Stock-Based Compensation
$87.41M
TTM · Period ending: · USD
FOLD Stock-Based Compensation
Latest reported$87.41Mperiod ending
Latest reported$87.41Mperiod ending
FOLD TTM Stock-Based Comp ($2.82M → $87.41M)
TTM stock-based compensation
High-resolution chart · PNG
FOLD stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 87,410,000 | |
| 80,037,000 | |
| 80,636,000 | |
| 79,274,000 | |
| 84,905,000 | |
| 65,688,000 | |
| 63,511,000 | |
| 63,891,000 | |
| 67,982,000 | |
| 86,608,000 | |
| 84,869,000 | |
| 80,755,000 | |
| 76,512,000 | |
| 71,793,000 | |
| 68,862,000 | |
| 68,135,000 | |
| 57,838,000 | |
| 43,931,000 | |
| 32,090,000 | |
| 28,762,000 | |
| 21,004,000 | |
| 33,912,000 | |
| 42,755,000 | |
| 44,282,000 | |
| 44,430,000 | |
| 39,909,000 | |
| 38,120,000 | |
| 34,526,000 | |
| 29,260,000 | |
| 26,907,000 | |
| 25,353,000 | |
| 24,549,000 | |
| 23,101,000 | |
| 21,484,000 | |
| 20,323,000 | |
| 19,251,000 | |
| 17,504,000 | |
| 16,130,000 | |
| 14,529,000 | |
| 12,295,000 | |
| 9,972,000 | |
| 8,539,000 | |
| 7,451,000 | |
| 6,708,000 | |
| 6,008,000 | |
| 5,901,000 | |
| 5,768,000 | |
| 5,863,000 | |
| 6,177,000 | |
| 6,122,000 | |
| 6,203,000 | |
| 6,377,000 | |
| 6,191,000 | |
| 6,179,000 | |
| 6,522,000 | |
| 8,649,000 | |
| 8,679,000 | |
| 8,727,000 | |
| 8,269,000 | |
| 5,888,000 | |
| 6,186,000 | |
| 6,450,000 | |
| 6,937,000 | |
| 7,531,000 | |
| 7,787,000 | |
| 12,485,000 | |
| 10,515,000 | |
| 8,418,000 | |
| 7,151,000 | |
| 3,521,000 | |
| 3,521,000 | |
| 3,521,000 | |
| 2,816,000 |